Sharma, SalilKhadimallah, InesCorya, Adam WilliamsonAli, Yousuf OmarRao, XiLiu, YunlongLu, Hui-Chen2019-01-172019-01-172018-06-18Sharma, S., Khadimallah, I., Corya, A. W., Ali, Y. O., Rao, X., Liu, Y., & Lu, H. C. (2018). Presymptomatic change in microRNAs modulates Tau pathology. Scientific reports, 8(1), 9251. doi:10.1038/s41598-018-27527-6https://hdl.handle.net/1805/18184MicroRNAs (miRs) are 18~23 nucleotides long non-coding RNAs that regulate gene expression. To explore whether miR alterations in tauopathy contribute to pathological conditions, we first determined which hippocampal miRs are altered at the presymptomatic and symptomatic stages of tauopathy using rTg4510 mice (Tau mice), a well-characterized tauopathy model. miR-RNA pairing analysis using QIAGEN Ingenuity Pathway Analysis (IPA) revealed 401 genes that can be regulated by 71 miRs altered in Tau hippocampi at the presymptomatic stage. Among several miRs confirmed with real-time qPCR, miR142 (-3p and -5p) in Tau hippocampi were significantly upregulated by two-weeks of age and onward. Transcriptome studies by RNAseq and IPA revealed several overlapping biological and disease associated pathways affected by either Tau or miR142 overexpression, including Signal Transducer and Activator of Transcription 3 (Stat3) and Tumor Necrosis Factor Receptor 2 (Tnfr2) signaling pathways. Similar to what was observed in Tau brains, overexpressing miR142 in wildtype cortical neurons augments mRNA levels of Glial Fibrillary Acidic Protein (Gfap) and Colony Stimulating Factor 1 (Csf1), accompanied by a significant increase in microglia and reactive astrocyte numbers. Taken together, our study suggests that miR alterations by Tau overexpression may contribute to the neuroinflammation observed in Tau brains.en-USAttribution 3.0 United StatesPresymptomatic changemicroRNAsTau pathologyGlial Fibrillary Acidic ProteinColony Stimulating Factor 1MicrogliaNeuroinflammationSignal TransducerActivator of Transcription 3Tumor Necrosis Factor Receptor 2Article